News Overview

Following the audit, the US FDA issued a Form 483 with 11 observations at closure, which Aurobindo Pharma described as small procedural observations.

India's industrial output growth slowed to a six-month low of 2.9% in February 2025, falling short of economists' expectations of 4% growth

The proposed issuance of ₹500 crore of NCDs may be done in one or more tranches over a period of 12 months from the date of the AGM.

For the quarter, net profit soared 49% on-year to ₹1,570 crore, on the back of higher revenue and better operating efficiency.

IIP fell sharply in February, and the prior revisions were only mildly positive in terms of growth traction

It was back to sell mode as FPIs were net sellers of $(2.47) Billion in the truncated second week of April 2025

Despite Trump putting reciprocal tariffs on pause, the China Syndrome continued to haunt the Indian markets

The next week will again be a truncated 3-day trading week, so VIX could stay elevated as traders stay light on positions

FMCG emerged as a rare bright spot as IT & Realty take a hit. Will optimism endure amidst the uncertainty? Dive into the week's market pulse

The total value of the sale from this auction was around ₹1,153.13 crore and, was a part of ongoing efforts in real estate monetisation by the company.